Clinical Trial

Linezolid Plus Standard of Care

Study acronym: LIPS
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-04-25; most recent amendment 2026-07-09.
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT06958835
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: Swiss National Science Foundation
Conditions Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
Enrollment 606 participants
Start Date 2025-10-06
Primary Completion 2028-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-13